Hendrik Riesenberg
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Cancer survivorship and care
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Oncology 5
- Cancer survivorship and care 3
- Cancer Diagnosis and Treatment 2
- Co-authors
- Andreas Stephan Lübbe (1 shared paper)Carsten Bokemeyer (1 shared paper)Djordje Atanackovic (1 shared paper)Martin Görner (2 shared papers)Frauke Müller (2 shared papers)A.S. Lübbe (2 shared papers)Peter Hirnle (1 shared paper)Susanne M. Lang (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Supportive Care in Cancer (1 paper)Strahlentherapie und Onkologie (1 paper)Lung Cancer (1 paper)HemaSphere (1 paper)
- Partner nations
- Germany
In The Last Decade
Hendrik Riesenberg
9 papers receiving 329 citations
Peers
Comparison fields: 5 of 46
- Hematology 153
- Oncology 145
- Pulmonary and Respiratory Medicine 82
- Genetics 16
- Otorhinolaryngology 5
Countries citing papers authored by Hendrik Riesenberg
This map shows the geographic impact of Hendrik Riesenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Riesenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Riesenberg more than expected).
Fields of papers citing papers by Hendrik Riesenberg
This network shows the impact of papers produced by Hendrik Riesenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Riesenberg. The network helps show where Hendrik Riesenberg may publish in the future.
Co-authors
The 10 scholars most cited alongside Hendrik Riesenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 126 | |
| 2 | 2009 | 85 | |
| 3 | 2013 | 63 | |
| 4 | 2024 | 40 | |
| 5 | 2012 | 13 | |
| 6 | 2008 | 5 | |
| 7 | 2011 | 4 | |
| 8 | 2007 | 2 | |
| 9 | 2022 | 2 | |
| 10 | 2025 | 0 |
About Hendrik Riesenberg
Hendrik Riesenberg is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Pharmacology and Genetics, having authored 10 papers that have together received 340 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Cancer survivorship and care (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Protein Degradation and Inhibitors (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Hematology (153 citations), Oncology (145 citations), Pulmonary and Respiratory Medicine (82 citations), Genetics (16 citations) and Otorhinolaryngology (5 citations). Hendrik Riesenberg has collaborated with scholars based in Germany. Frequent co-authors include Andreas Stephan Lübbe, Carsten Bokemeyer, Djordje Atanackovic, Martin Görner, Frauke Müller, A.S. Lübbe, Peter Hirnle, Susanne M. Lang, Hans‐Björn Gehl and Birol Baysal. Their work appears in journals such as Journal of Clinical Oncology, Supportive Care in Cancer, Strahlentherapie und Onkologie, Lung Cancer and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.